Xcout Intel
FoRx Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to FoRx Therapeutics among biotech companies — ranked by similarity to what FoRx Therapeutics actually does, not by market-cap band.
Subscribe to see FoRx Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About FoRx Therapeutics
FoRx Therapeutics is a privately held clinical-stage biotechnology company headquartered in Basel, Switzerland. The company pioneers precision therapeutics targeting DNA Replication Stress in cancer treatment. Its office is located at Lichtstrasse 35, 4056 Basel, Switzerland.
FoRx Therapeutics at a glance
FoRx Therapeutics is a biotech company headquartered in Switzerland. Xcout tracks 9 named people at FoRx Therapeutics, including Tarig Bashir (Chief Executive Officer (CEO)).
FoRx Therapeutics leadership
- Tarig BashirChief Executive Officer (CEO)
- Michael KauffmanExecutive Chairman
- Robert BrownChairman of the Board
- Beat SteffenBoard Member
- Christian UhrichBoard Member
- Emily ChenBoard Member
3 more named people on record for FoRx Therapeutics, with roles, board committees and tenure — see the full roster →
Top 12 FoRx Therapeutics competitors
Ranked by semantic similarity — how close each company is to FoRx Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Fore Biotherapeutics is a virtual precision oncology company rooted in science and innovation, with expertise and talent across the USA. The company is focused on developing treatments, including its Plixorafenib Program.
Biotechnology
DCx Biotherapeutics is a Canadian preclinical-stage biotechnology company developing precision oncology therapeutics and precision drug conjugates to target genetically defined cancers. The company focuses on addressing root drivers and key cellular interdependencies of cancer lesions.
Biotechnology
Nested Therapeutics is a privately held biotech company headquartered in Cambridge, Massachusetts, focused on advancing precision oncology medicine by uncovering hidden driver mutations.
Biotechnology
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Biotechnology
Apeiron Therapeutics is a clinical-stage biopharmaceutical and precision oncology company focused on developing biomarker-driven therapeutics for cancer.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Biotechnology
Nerai Bioscience AG is a biotechnology company headquartered in Zurich, Switzerland, that is focused on redefining genetic medicine.
Biotechnology
Base Therapeutics is a biotechnology company that develops next-generation gene editing technologies, including its proprietary AccuBase base editing system and enhanced prime editing technology. The company focuses on creating therapeutic solutions for cancer and genetic diseases, alongside engineered immune cell therapies such as BASE-NK and CAR-T products. It serves patients and partners with pharmaceutical and agricultural enterprises by licensing its precision gene editing tools.
Biotechnology
Alterome Therapeutics, Inc. is a clinical-stage precision oncology company headquartered in San Diego, California, founded in 2021. The privately held biotech firm focuses on developing targeted therapies to address genomically defined cancer drivers and intractable oncological targets.
Similar biotech company
Mirador Therapeutics, Inc. is a clinical-stage precision medicine company headquartered in San Diego, California, focused on developing first- and best-in-class next-generation therapeutics.
Similar biotech company
IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and advancement of precision anti-cancer treatments rooted in synthetic lethality, operating across China and international markets. The company's primary offering, Senaparib (IMP4297), is a PARP1/2 inhibitor currently deployed as a first-line maintenance therapy for ovarian cancer. Beyond this, Impact Therapeutics maintains a robust pipeline of investigational drugs. This includes IMP1734, a next-generation PARP1 selective inhibitor undergoing Phase I/II trials as a standalone treatment for advanced solid tumors. Another promising candidate is IMP9064, an ATR kinase selective inhibitor, also in Phase I/II clinical studies for advanced solid tumors as a monotherapy. IMP1707, a PARP1 selective inhibitor capable of penetrating the central nervous system, is in Phase I development for homologous recombination repair-deficient tumors. Additionally, IMP7068, an advanced WEE1 inhibitor, is progressing through Phase I/II clinical trials for various advanced solid tumors. Furthermore, a range of other compounds, namely IMP22, IMP25, IMP08, IMP13, IMP10, IMP27, and IMP32, are in the preclinical development phase. The company, established in 2009, is headquartered in Shanghai, China.
Similar biotech company
AUM Biosciences is a clinical-stage biotechnology company that develops precision oncology therapeutics utilizing multi-faceted inhibition strategies to overcome cancer drug resistance. The company serves patients and the healthcare sector by advancing a targeted clinical pipeline designed to combat tumor evasion and treatment resistance.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of FoRx Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for FoRx Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →